Alberts A, Kjaer SK, Søegaard SH, Winther JF, Schmiegelow K, Sopina L Erdmann F, Hargreave M. Childhood vaccinations and the risk of leukemia: A nationwide cohort study. Int J Cancer 2025;157(1):55–63. https://doi.org/10.1002/ijc.35338

Amund Henriksen K, Van Overeem Hansen T, Wadt K, Schmiegelow K, Foss- Skiftesvik J, Stoltze UK. Evolutionary evidence precludes ELP1 as a high- penetrance pediatric cancer predisposition syndrome gene. Neurooncol Adv. 2024 Sep 24;6(1):vdae165. doi: 10.1093/noajnl/vdae165. Erratum in: Neurooncol Adv. 2025 Feb 21;7(1):vdae213. doi: 10.1093/noajnl/vdae213.

Andersen M.M, Sørensen M.C.L, Schmiegelow K, Sehested A, Rostgaard K, Olsen M, Mikkelsen T.S, Wehner P.S, Hjalgrim L.L, Søegaard S.H. Relapse and survival after relapse among children with cancer in Denmark: 2001–2021. Ped Blood Cancer 2025;72:e31384

Christiansen J, Mathiasen R, Heegaard S, Kjeldsen S, Schmiegelow K, Siersma V, von Holstein S. Early ophthalmological tumour signs and diagnostic interval in children with brain tumours. Eye (Lond). 2025 May 17. doi: 10.1038/s41433-025-03837-8. Online ahead of print. https://doi.org/10.1038/s41433-025-03837-8

Curran E, Luskin MR, Alachkar H, Aldoss I, Burke PW, Cassaday RD, Karol SE, Perissinotti AJ, Rank CU, Schmiegelow K, Webster J, Douer D. Recognition, prevention, and management of adverse events associated with asparaginase / pegaspargase treatment of acute lymphoblastic leukemia in adults: consensus of an expert panel” Haematologia 2025 Mar 20. https://doi:10.3324/haematol.2024.286744. Online ahead of print.

Gerbek T, Holmqvist AS, Linnet KM, Pedersen C, de Fine Licht S, Christensen J, Krøyer A, Mogensen H, Feychting M, Wiebe T, Hjorth L, Lassen-Ramshad Y, Lähteenmäki PM, Rechnitzer C, Hasle H, Kenborg L. Late-onset epilepsy in survivors of childhood cancer outside the central nervous system: a study within the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study. J Cancer Surviv 2025 Apr 16. https://doi.org/10.1007/s11764-025-01795-4

Hackenhaar F.S, Refhagen N, Hagleitner M, van Leeuwen F, Marquart HV, Madsen HO, Landfors M, Osterman P, Schmiegelow K, Flaegstad T, Jónsson Ó, Kanerva J, Abrahamsson J, Heyman M, Norén Nyström U, Hultdin M, Degerman S. CpG island methylator phenotype classification improves risk assessment in pediatric T-cell Acute Lymphoblastic Leukemia. Blood 2025;145(19):2161–2178. https://doi.org/10.1182/blood.2024026027

Hemmingsen CH, Kjaer SK, Hjorth S, Nörby U, Broe A, Pottegård A, Bénévent J, Schmiegelow K, Skovlund CW, Leinonen MK, Nordeng H, Mørch LS, Hargreave M. Maternal use of hormonal contraception and risk of childhood leukemia: a Scandinavian population-based cohort study. Eur J Cancer 2025;215:115168. https://doi.org/10.1016/j.ejca.2024.115168

Kenborg L, Asdahl PH, Bhatia S, Christensen J, Gudmundsdottir T, Hjorth L, Howell R, Krøyer A, Jørgensen M, Laursen MRT, Lassen-Ramshad Y, de Fine Licht S, Nielsen TT, Rechnitzer C, Smith SA, Wiebe T, Hasle H, Holmqvist AS.  Treatment-Related Risk Factors for Diabetes Mellitus in Childhood Cancer Survivors-A Case-Cohort Study Within Adult Life After Childhood Cancer in Scandinavia (ALiCCS). Pediatric Blood & Cancer 2025; 72: e31805. https://doi.org/10.1002/pbc.31805

Nielsen AB, Holm M, Lindhard MS, Glenthøj JP, Borch L, Hartling U, Schmidt LS, Rytter MJH, Rasmussen AH, Damkjær M, Lemvik G, Petersen JJH, Søndergaard MJ, Thaarup J, Kristensen K, Jensen LH, Hansen LH, Lawaetz MC, Gottliebsen M, Horsager TH, Zaharov T, Hoffmann TU, Nygaard T, Justesen US, Stensballe LG, Vissing NH, Blanche P, Schmiegelow K, Nygaard U. Oral versus intravenous empirical antibiotics in children and adolescents with uncomplicated bone and joint infections: a nationwide, randomised, controlled, non-inferiority trial in Denmark. Lancet Child Adolescent Health 2024; 8: 625-35 https://doi.org/10.1016/s2352-4642(24)00133-0

Meyer SI, Skipper MT, Andrés Jensen L, Christensen KM, Tuckuviene R, Wehner PS, Albertsen BK, Schmiegelow K, Frandsen TL, Nielsen KG, Nielsen AM, Andersen DH, Rubak SLM. Late pulmonary adverse effects in childhood and adolescent acute lymphoblastic leukaemia survivors: a cross sectional ALL STAR Lungs study. ERJ Open Res 2025 (in press). https://doi.org/10.1183/23120541.00350-2025

Nazerai L, Tsiavou C, Vardouli L, Schmiegelow K, De Zio. Thiopurine therapy enhances immune checkpoint inhibitor efficacy in low-mutational burden melanoma: A promising anticancer approach. Proc Natl Acad Sci U S A 2025; 122(9):e2423246122. https://doi.org/10.1073/pnas.2423246122

Nielsen AB, Holm M, Blanche P, Nygaard T, Nygaard U. on behalf of the Danish CHILD study group (Lindhard MS,  Glenthøj JP, Borch L, Hartling U, Schmidt LSS, Rytter MJH, Rasmussen AH, Damkjær M, Lemvik G, Petersen JJH, Søndergaard MJ, Thaarup J, Kristensen K, Jensen LH, Hansen LH, Lawaetz MC, Gottliebsen M, Horsager TH, Zaharov T, Hoffmann TU, Justesen US, Stensballe LG, Vissing NH, Schmiegelow K. One-year follow-up of oral versus intravenous initial antibiotics in children and adolescents with uncomplicated bone and joint infections: a nationwide, randomised, controlled, non inferiority trial in Denmark. The Lancet Child and Adolescent Health, 2025 Apr;9(4):e10-e11. https://doi.org/10.1016/s2352-4642(25)00026-4

Raja RA, Als-Nielsen B, Lund AM, Vilstrup H, Dalhoff KP, Schmiegelow K. Asparaginase associated hyperammonemia. Haematologica, 2025 Apr 24. https://doi.org/10.3324/haematol.2025.287301 Online ahead of print.

Skipper MT, Birkebæk N, Jensen RB, Langdahl BL, Tuckuviene R, Wehner PS, Schmiegelow K, Frandsen TL, Andrés-Jensen L, Albertsen BK. Risk of metabolic syndrome and glucose homeostasis among childhood and young adult acute lymphoblastic leukemia survivors: part of the ALL-STAR study. Ped Blood & Cancer, 2025 Jul;72(7):e31705. https://doi.org/10.1002/pbc.31705 Epub 2025 Apr 29.

Stegenborg F, Bek MS, Nilsson CJ, Pedersen LH, Scheike T, Hjalgrim LL, Erdmann F, Schmiegelow K, Bidstrup P, Kenborg L, Winther JF, Larsen HB, Dalton SO. Socioeconomic characteristics and relapse-free and overall survival from childhood cancer – a nationwide study based on data from the Danish Childhood Cancer Registry. Acta Oncologica 2025;64,42131 https://doi.org/10.2340/1651-226x.2025.42131

Stoltze U, Junk SV, Byrjalsen A, Cavé H, Cazzaniga G, Elitzur S, Fronkova E, Hjalgrim LL, Kuiper RP, Lundgren L, Mescher M, Mikkelsen T, Pastorczak A, Strullu M, Trka J, Wadt K, Izraeli S, Borkhardt A, Schmiegelow K. Overt and covert genetic causes of pediatric acute lymphoblastic leukemia. Leukemia. 2025 May;39(5):1031-1045. https://doi.org/10.1038/s41375-025-02535-4 Epub 2025 Mar 24.

Toksvang LN, Brigitha LJ, van der Sluis IM, Brivio E, Raja R, Pontoppidan P, Rasmussen ASB, Andrés Jensen L, Uhlving HH, Kielsen K, Als-Nielsen B, Elitzur S, Dalhoff  K, Schmiegelow K, Rank CU. Therapeutic drug monitoring in acute lymphoblastic leukemia – a deep dive into pharmacokinetics, dynamics, and genetics of antileukemic drugs. Expert Rev Clin Pharmacol 2025 Mar;18(3):131–149. https://doi.org/10.1080/17512433.2025.2465426

Taalas TL, Oskarsson T, Heyman M, Lund B, Lepik K, Vaitkeviciene G, Jonsson OG, Eriksson J, Toft N, Griskevicius L, Hallbook H, Palk K, Wartiovaara-Kautto U, Quist-Paulsen P, Noren-Nystrom U, Vettenranta K, Abrahamsson J, Schmiegelow K, Lahteenmaki PM. Impact of age and sex on survival outcomes in patients aged 1–45 years with acute lymphoblastic leukemia treated according to NOPHO ALL2008 trial. Haematologica 2025 Feb 20. https://doi:10.3324/haematol.2024.286043 Online ahead of print

Anastasopoulou S, Swann G, Andres-Jensen L, Attarbaschi A, Barzilai-Birenboim S, Erdelyi DJ, Escherich G, Hamadeh L, Harila A, Lopez-Lopez E, McGowan S, Möricke A, Putti C, Sagi JC, Schmiegelow K, Ullrich NJ, van der Sluis IM, Wahid QU Winick N, Sramkova L, Zalcberg Y, Zapotocka E, Bhojwani D, Halsey C.; Ponte Di Legno Neurotoxicity Working Group. Severe steroid-related neuropsychiatric symptoms during paediatric acute lymphoblastic leukaemia therapy-An observational Ponte di Legno Toxicity Working Group Study. Br J Haematol. 2024; https://doi.org/10.1111/bjh.19610

Aukstikalne L, Klejus I, Thastrup M, Zvirblis T, Schmiegelow K, Vaitkeviciene G. E, &  Toksvang L. N. (2023). Erythrocyte-incorporated 6-mercaptopurine metabolite levels are not affected by recent drug administration during maintenance therapy for childhood acute lymphoblastic leukemia. EJC Paediatric Oncology, 2, 100028. https://doi:10.1016/j.ejcped.2023.100028

Bayoumy AB, Ansari AT, Mulder CJJ, Schmiegelow K, Florin T, De Boer NKH. Innovating Thiopurine Therapeutic Drug Monitoring: A Systematic Review and Meta-Analysis on DNA-Thioguanine Nucleotides (DNA-TG) as an Inclusive Biomarker in Thiopurine Therapy. Clin Pharmacokinet 2024; https://doi.org/10.1007/s40262-024-01393-0

Buhl Rasmussen AS, Andersen CL, Weimann A, Yang T, Tron C, Gandemer V, Dalhoff K, Rank CU, Schmiegelow K. Therapeutic drug monitoring of imatinib – how far are we in the leukemia setting? Expert Rev Clin Pharmacol. 2024;17:225-234. https://doi.org/10.1080/17512433.2024.2312256

Dybedokken A, Mathiesen R, Hasle H, Herlin T, Callesen MT, Hansen SH, Jensen LH, Amstrup J, Hagstrøm S, Brix N. Musculoskeletal misdiagnoses in pediatric patients with spinal tumors. Pediatric Blood & Cancer 2024; 71: e31024. https://doi.org/10.1002/pbc.31024

Elitzur S, Shiloh R, Loeffen JLC, Pastorczak A, Takagi M, Bomken S, Baruchel A, Lehrnbecher T, Tasian SK, Abla O, Arad-Cohen N, Astigarraga .I, Ben-Harosh M, Bodmer N, Brozou T, Ceppi F, Chugaeva L, Dalla-Pozza L, Ducassou S, Escherich G, Farah R, Gibson A, Hasle H, Hoveyan J, Jacoby E, Jazbec J, Junk SV, Kolenova A, Lazic J, Lo Nigro L, Mahlaoui N, Miller LH, Papadakis V, Pecheux L, Pillon M, Sarouk I, Stary J, Stiakaki E, Strullu M, Tran TH, Ussowicz M, Verdu-Amorós J, Wakuliñska AZ, Zawitkowska J, Stoppa-Lyonnet D, Taylor AM, Shiloh Y, Izraeli S, Minard-Colin V, Schmiegelow K, Nirel R, Attarbaschi A, Borkhardt A. ATM germline pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies. Blood. 2024; https://doi:10.1182/blood.2024024283

Hammer-Hansen S, Stoltze U, Bartels E, Hansen TVO, Byrjalsen A, Tybjærg-Hansen A, Juul K, Schmiegelow K, Tfelt J, Bundgaard H, Wadt K, Diness BR. Actionability and familial uptake following opportunistic genomic screening in a pediatric cancer cohort. Eur J Hum Genet 2024; 32:846-857. https://doi.org/10.1038/s41431-024-01618-7

Hansen HK, Asdahl PH, Christensen J, Pedersen C, Krøyer A, Pontoppidan CS, Holmqvist AS, Hjorth L, Wiebe T, Gudmundsdottir T, de fine Licht S, Lassen-Ramshad Y, Seiersen K, Jørgensen M, Laursen MR, Øfstaas H, Lähteenmäki PM, Smith SA, Howell R, Rechnitzer C, Hasle H, Winther JE, Kenborg L. Risk of severe esophageal stricture among childhood cancer survivors – A population-based case-cohort study within the Adult Life after Childhood Cancer in Scandinavia (ALiCCS). EJC Paediatric Oncology 2024; 4, 100195 https://doi.org/10.1016/j.ejcped.2024.100195

He P, Dumont E, Göksel Y, Slipets R, Schmiegelow K, Chen Q, Zor K, Boisen A. (2024) SERS mapping combined with chemometrics, for accurate quantification of methotrexate from patient samples. pectrochim Acta A Mol Biomol Spectrosc. 2024;305:123536. https://doi:10.1016/j.saa.2023.123536

Mirian C, Thastrup M, Mathiasen R, Schmiegelow K, Olsen JV, Østergaard O. Mass spectrometry-based proteomics of cerebrospinal fluid in pediatric central nervous system malignancies: a systematic review with meta-analysis of individual patient data. Fluids Barriers CNS. 2024; 21:14. https://doi.org/10.1186/s12987-024-00515-x

Mogensen H, Erdmann F, Mader L, Sørensen GV, Talbäck M, Nielsen TT, Hasle H, Heyman M, Winther JF, Feychting M, Tettamanti G, Kenborg L. Early mortality in children with cancer in Denmark and Sweden: The role of social background in a setting with universal healthcare. International Journal of Cancer 2024; 154: 1719-30. https://doi.org/10.1002/ijc.34851

Mogensen H, Tettamanti G, Frederiksen LE, Talbäck M, Härkonen J, Modig K, Pedersen C, Krøyer A, Hirvonen E, Kyrönlahti A, Heyman M, Holmqvist AS, Hasle H, Madanat-Harjuoja L, Malila N, Winther JF, Erdmann F, Feychting M. Educational attainment in survivors of childhood cancer in Denmark, Finland, and Sweden. British Journal of Cancer 2024; 130: 260-268. https://doi.org/10.1038/s41416-023-02499-1

Moorman AV, Enshaei A, Murdy D, Joy M, Boer JM, den Boer ML, Pieters R, de Haas V, Horstmann MA, Escherich G, Johansson B, Marquart HV, Schmiegelow K, Hancock J, Moppett J, Heyman M. Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction. Leukemia. 2024. https://doi.org/10.1038/s41375-024-02329-0

Rosenberg JG, Nissen K, Heegaard S, Ragunathan S, Schmiegelow K, Mathiasen R, von Holstein SL. Nystagmus in children with primary brain tumours in Denmark between 2007 and 2017. Eye (Lond) 2024;38:766-772. https://doi.org/10.1038/s41433-023-02771-x

Stoltze UK, Foss-Skiftesvik J, Hansen vOT, Rasmussen S, Karczewski KJ, Wadt KAW, Schmiegelow K. The Evolutionary Impact of Childhood Cancer on the Human Gene Pool. Nature Comm 2024 Feb; 15(1): 1881. https://doi.org/10.1038/s41467-024-45975-9

Stoltze UK, Hansen T, Foss-Skiftesvik J, Byrjalsen A, Henriksen K, Laspiur A, et al. Causal germline variants in children with cancer. SSRN [Preprint]. 2024. https://doi.org/10.2139/ssrn.4889581

Skipper MT, Birkebæk M, Jensen RB, Rank CU, Tuckuviene R, Wehner PS, Lambine T-L, Hørlyck A, Schmiegelow K, Frandsen T, Andrés-Jensen L*, Albertsen BK. Pancreas-related persisting sequelae in ALL survivors with a history of asparaginase-associated pancreatitis – a part of the ALL-STAR study. Eur J Haematol 2024; 112:944-956. https://doi.org/10.1111/ejh.14189

Søegaard SH, Andersen MM, Rostgaard K, Davidsson OB, Olsen SF, Schmiegelow K, Hjalgrim H. Exclusive Breastfeeding Duration and Risk of Childhood Cancers. JAMA Netw Open 2024; 7: e243115. https://doi.org/10.1001/jamanetworkopen.2024.3115

Sørensen GV, Mogensen H, Holmqvist AS, Kenborg L, Pedersen C, Nielsen TT, Talbäck M, Erdmann F, Ifversen M, Feychting M, Schmiegelow K, Heyman MM, Winther JF, Hasle H, Frederiksen LE. Psychiatric disorders among survivors of childhood acute lymphoblastic leukemia in Denmark and Sweden. Pediatric Blood & Cancer 2024; 71: e31361. https://doi.org/10.1002/pbc.31361

Sørensen MCL, Andersen MM, Rostgaard K, Schmiegelow K, Mikkelsen TS, Wehner PS, Olsen M, Søegaard SH, Hjalgrim LL. Treatment-related mortality among children with cancer in Denmark during 2001-2021. Acta Oncol 2024; 7;63:294-302. https://doi.org/10.2340/1651-226x.2024.27731

Thorsson H, Henningsson R, Puente-Moncada N, Peña-Martínez P, Sjöström L, Ågerstam H, Sandén C, Rissler M, Castor A, Marquart HVH, Modvig S, Paulsson K, Pronk CJ, Schmiegelow K, Hyrenius-Wittsten A, Orsmark-Pietras C, Lilljebjörn H, Fioretos T. Single-cell genomics details the maturation block in BCP-ALL and identifies therapeutic vulnerabilities in DUX4-r cases. Blood 2024; https://doi.org/10.1182/blood.2023021705

Turanzas NJ, Mathiasen R, Heegaard S, Schmiegelow K, Sehested A, Holtz JK, Siersma V, Nissen KR, von Holstein SL. Ophthalmic symptoms, clinical signs and diagnostic delay in infants diagnosed with brain tumours in Denmark between 2007 and 2017. Acta Ophthalmol. 2024; 102:334-341. https://doi.org/10.1111/aos.15745

Weibel, M, Bergdahl, N, Hallström, I.K. et al. Robots2school: telepresence-mediated learning in the hybrid classroom – experiences in education support for children during cancer treatment: a qualitative study. Educ Inf Technol. 2024;29:11339–11366. https://doi:10.1007/s10639-023-12243-0

Weile KS, Helligsoe ASL, von Holstein SL, Winther JF, Mathiasen R, Hasle H, Henriksen LT. Patient- and parent-reported diagnostic delay in children with central nervous system tumors in Denmark. Pediatric Blood & Cancer 2024; 71: e31128. https://doi.org/10.1002/pbc.31128

Weile KS, Mathiasen R, Winther JF, Hasle H, Henriksen LT. Hjernetegn.dk – The Danish Central Nervous System Tumor Awareness Initiative Digital Decision Support Tool: Design and Implementation Report. JMIR Medical Informatics 2024; 12: e58886. https://doi.org/10.2196/58886

Attarbaschi A. Möricke A. Harrison CJ, Mann G, Baruchel A, Moerloose BD, Conter V, Devidas M, Elitzur S, Escherich G, Hunger SP, Horibe K, Manabe A, Loh ML, Pieters R, Schmiegelow K, Silverman LB, Stary J, Vora A, Pui C-H, Schrappe M., Zimmermann M.; on behalf of the Ponte di Legno Childhood Acute Lymphoblastic Leukemia Working Group. Outcome of childhood non-infant acute lymphoblastic leukemia with 11q23/KMT2A-rearrangements in a modern therapy era – a retrospective international study of 629 patients. J Clin Oncol 2023; 41: 1404-22. https://doi.org/10.1200/jco.22.01297

Byrjalsen A, Stoltze U, Mehrjouy M, Frederiksen JH, Bak M, Birkedal U, Hasle H, Gerdes AM, Schmiegelow K, Wadt K, Hansen TVO. The effect of a single SMARCA4 exon deletion on RNA splicing: Implications for variant classification. Mol Genet Genomic Med. 2023 Oct;11(10):e2232. https://doi.org/10.1002/mgg3.2232  Epub 2023 Jul 10.

Elitzur S, Vora A, Burkhardt B, Inaba H, Attarbaschi A. Baruchel A, Escherich G, Gibson BE, Liu HC, Loh ML, Moorman AV, Möricke A, Pieters R, Uyttebroeck A, Baird S, Bartram J, Barzilai-Birenboim S, Batra S, Ben-Harosh M, Bertrand Y, Buitenkamp T, Caldwell K, Drut R, Geerlinks AV, Gilad G, Grainger J, Haouy S, Heaney NB, Huang M, Ingham D, Krenova Z, Kuhlen M, Lehrnbecher T, Manabe A, Niggli F, Paris C, Revel-Vilk S, Rohrlich P, Sinno MG, Szczepanski T, Tamesberger M, Warrier R, Wolfl M, Nirel R, Izraeli S, Borkhardt A, Schmiegelow K. EBV-driven lymphoid neoplasms associated with pediatric ALL maintenance therapy. Blood 2023; 141: 743-55. https://doi.org/10.1182/blood.2022016975

Egnell C, Hallböök H, Heyman M, Wartiovaara-Kautto U, Quist-Paulsen P, Schmiegelow K, Griskevicius L, Palk K, Toft N, Overgaard UM, Harila A, Ranta S. Impact of body mass index on outcome and treatment-related toxicity in young adults with acute lymphoblastic leukemia. Acta Oncol. 2023 Dec;62(12):1723-1731. https://doi.org/10.1080/0284186x.2023.2258450  Epub 2023 Nov 25.

Fridh MK, Schmidt‑Andersen P, Andres‑Jensen L, Thorsteinsson T, Wehner PS, Hasle H, Schmiegelow K, Larsen HB. Children with cancer and their cardiorespiratory fitness and physical function—the long‑term effects of a physical activity program during treatment: a multicenter non‑randomized controlled trial. J Cancer Surviv. 2025. Apr;19(2):672-684. https://doi.org/10.1007/s11764-023-01499-7  Epub 2023 Dec 6.

Foss-Skiftesvik J*, Li S*, Rosenbaum A*, Hagen CM, Stoltze UK, Ljungqvist S, Hjalmars U, Schmiegelow K, Morimoto L, de Smith AJ, Mathiasen R, Metayer C, Hougaard D, Melin B, Walsh KM, Bybjerg-Grauholm J**, Dahlin AM**, Wiemels JL*. Multi-ancestry genome-wide association study of 4,069 children with glioma identifies 9p21.3 risk locus. Neuro-Oncology 2023; 25:1709-1720. http://dx.doi.org/10.1093/neuonc/noad137.042

Foss-Skiftesvik J, Mathiasen R, van Overeem Hansen T, Wadt K, Schmiegelow K, Stoltze UK. Molecular reclassification reveals low prevalence of germline predisposition in children with ependymoma. Acta Neuropathol Commun. 2023 Jun 12;11(1):94. https://doi.org/10.1186/s40478-023-01594-x

Gebhard A, Lilienthal P, Metzler M, Rauh M, Sager S, Schmiegelow K, Toksvang LN, Zierk J. Pharmacokinetic-pharmacodynamic modeling of maintenance therapy for childhood acute lymphoblastic leukemia. Sci Rep. 2023 Jul 20;13(1):11749. https://doi.org/10.1038/s41598-023-38414-0

Hammer NM, Bidstrup PE, Brok J, Devantier M, Sjøgren P, Schmiegelow K, Larsen A, Kurita GP, Olsen M, Larsen HB. Home-based specialized pediatric palliative care: a systematic review and meta-analysis. J Pain Symptom Manage. 2023;65(4):e353–e368. https://doi.org/10.1016/j.jpainsymman.2022.12.139

Hammer NM, Hansson H, Pedersen LH, Abitz M, Sjøgren P, Schmiegelow K, Bidstrup P, Bækgaard Larsen H, Olsen M. Intersectoral collaboration in home-based end-of-life pediatric cancer care: A qualitative study integrating families’ and professionals’ experiences. Palliative Medicine 2023 Jan; 37(1):149-162. https://doi.org/10.1177/02692163221135350  Epub 2022 Nov 17

Høeg B.L.*, Barrios Sevillano P*, Enesco I, Wakefield CE, Larsen HB, Bidstrup PE. Child-centered communication interventions in pediatric oncology: A scoping review and proposed new communication model. Pediatr Blood Cancer. 2023 Jul;70(7):e30533. https://doi.org/10.1002/pbc.30533

Høgsholt S, Asdahl PH, Rechnitzer C, Winther JF, Birn H, Hasle H. Kidney disease in very long-term survivors of Wilms tumor: A nationwide cohort study with sibling controls. Cancer Med. 2023 Jan;12(2):1330-1338. https://doi.org/10.1002/cam4.5010  Epub 2022 Jul 16.

Kimura S, Polonen P, Montefiori L, Park CS, Iacobucci I, Yeoh AEJ, Attarbaschi A, Moore AS, Brown A, Manabe A, Buldini B, Freeman BB, Chen C, Cheng C, Hui CK, Li CK, Pui CH, Qu C, Tomizawa D, Teachey DT, Varotto E, Paietta EM, Arnold ED, Locatelli F, Escherich G, Muhle HE, Marquart HV, de Groot-Kruseman HA, Rowe JM, Stary J, Trka J, Choi JK, Meijerink JPP, Yang JJ, Takita J, Pawinska-Wasikowska K, Roberts KG, Han K, Caldwell KJ, Schmiegelow K, Crews KR, Eguchi M, Schrappe M, Zimmerman M, Takagi M, Maybury M, Svaton M, Reiterova M, Kicinski M, Prater MS, Kato M, Reyes N, Spinelli O, Thomas P, Mazilier .P, Gao Q, Masetti R, Kotecha RS, Pieters R, Elitzur S, Luger SM, Mitchell S, Pruett-Miller SM, Shen S, Jeha S, Köhrer S, Kornblau SM, Skoczeń S, Miyamura T, Vincent TL, Imamura T, Conter V, Tang Y, Liu YC, Chang Y, Gu Z, Cheng Z, Yinmei Z, Inaba H, Mullighan CG. Biologic and clinical features of childhood gamma delta T-ALL: identification of STAG2/LMO2 γδ T-ALL as an extremely high-risk leukemia in the very young. medRxiv. 2023 Nov 6; http://dx.doi.org/10.1101/2023.11.06.23298028

Laumann RD, Pedersen LL, Andrés-Jensen L, Mølgaard C, Schmiegelow K, Frandsen TL, Als-Nielsen B. Hyperlipidemia in children and adolescents with acute lymphoblastic leukemia: A systematic review and meta-analysis. Pediatr Blood Cancer. 2023 Dec;70(12):e30683. https://doi.org/10.1002/pbc.30683 Epub 2023 Sep 30.

Nielsen CG, Thomsen BL, Als-Nielsen B, Conyers R, Jeha S, Mateos MK, Mlynarski W, Pieters R, Rathe M, Schmiegelow K, Andrés-Jensen L. Physician-defined severe toxicities occurring during and after cancer treatment: Modified consensus definitions and clinical applicability in the evaluation of cancer treatment Front Pediatr 2023 Apr 26;11:1155449. https://doi.org/10.3389/fped.2023.1155449

Norén-Nyström U, Andersen MK, Barbany G, Dirse V, Eilert-Olsen M, Engvall M, Harila-Saari A, Heyman M. Hovland R, Häikiö S,  Jónsson JJ, Karhu R, Kjeldsen E., Norberg A,  Preiss BS, Pulkkinen K, Quist-Paulsen P, Räsänen H, Schmiegelow K, Seitsonen A, Sjögren H, Tammur P, Johansson N. Genetic Subtypes and Outcome of Patients Aged 1 to 45 Years Old With Acute Lymphoblastic Leukemia in the NOPHO ALL2008 Trial. Hemasphere 2023; 7: e883. https://doi.org/10.1097/hs9.0000000000000883

Öfverholm I*, Rezayee F*, Heyman M, Harila-Saari A, Arvidsson L, Schmiegelow K, Norén-Nyström U, Barbany G. The prognostic impact of IKZF1 deletions and UKALL genetic classifiers in paediatric B-cell precursor acute lymphoblastic leukaemia treated according to NOPHO 2008 protocols. Br J Haematol 2023; 202: 384-92. https://doi.org/10.1111/bjh.18852

Petersen N, Weibel M, Wakefield CE, Bidstrup PE, Olsen M, Nissen KB, Fridh MK, Larsen HB. A qualitative study exploring online social interactions from the experiences of children with cancer, classmates, study nurses, and teachers. SSRN Electron J. 2023. http://dx.doi.org/10.2139/ssrn.4395322

Raetz EA, Rebora P, Conter V, Schrappe M, Devidas M, Escherich G, Imai C, De Moerloose B, Schmiegelow K, Burns MA, Elitzur S, Pieters R, Attarbaschi A, Yeoh A, Pui CH, Stary J, Cario G, Bodmer N, Moorman AV, Buldini B, Vora A, Valsecchi MG. Outcome for Children and Young Adults With T-Cell ALL and Induction Failure in Contemporary Trials. J Clin Oncol 2023; 41: 5025-34. https://doi.org/10.1200/jco.23.00088

Roug, L.I, Wahlberg, A, Jarden, M, Hjalgrim, L.L. & Hansson, H. Ambiguous expectations of parent caregiving for the child and adolescent with cancer at the hospital and at home: an ethnographic study. Journal of Pediatric Hematology/ Oncology Nursing. J Pediatr Hematol Oncol Nurs. 2023 Mar-Apr;40(2):100-110. https://doi:10.1177/27527530221140065  Epub 2023 Jan 10

Skipper MT, Albertsen BK, Schmiegelow K, Andrés-Jensen L. Long-term effects of asparaginase-associated pancreatitis. Ped Blood Cancer 2023 Jun 28: e30528. https://doi.org/10.1002/pbc.30528

Sora V, Laspiur AO, Degn K, Arnaudi M, Utichi M, Beltrame L, De Menezes D, Orlandi M, Stoltze UK, Rigina O, Sackett PW, Wadt K, Schmiegelow K, Tiberti M, Papaleo E. RosettaDDG Prediction for high-throughput mutational scans: From stability to binding. Protein Sci. 2023 Jan;32(1):e4527. https://doi.org/10.1101/2022.09.02.506350

Soufi G, Dumont E, Göksel Y, Slipets R, Raja RA, Schmiegelow K, Bagheri H, Boisen A, Zor K. Discrimination and quantification of methotrexate in the presence of its metabolites in patient serum using SERS mapping, assisted by multivariate spectral data analysis. Biosensors and Bioelectronics: X. 2023;14:100382. https://doi.org/10.1016/j.biosx.2023.100382

Stoltze UK, Hagen CM, van Overeem Hansen T, Byrjalsen A, Gerdes AM, Yakimov V, Rasmussen S, Bækvad-Hansen M, Hougaard DM, Schmiegelow K, Hjalgrim H, Wadt K, Bybjerg-Grauholm J. Combinatorial batching of DNA for ultralow-cost detection of pathogenic variants. Genome Medicine 2023; 15: 17. https://doi.org/10.1186/s13073-023-01167-6

Stoltze UK, Hansen TVO, Brok JS, Grønskov K, Tumer AZ, Ahlborn LB, Schmiegelow K, Wadt KAW. Maternal versus paternal inheritance of a 132 bp 11p15.5 microdeletion affecting KCNQ1OT1 and associated phenotypes. J Med Genet. 2023 Feb;60(2):128-130. https://doi.org/10.1136/jmedgenet-2021-108335

Stoltze UK, Hildonen M, Hansen TvO, Foss-Skiftesvik J, Byrjalsen A, Lundsgaard M, Pignata L, Grønskov K, Tumer Z, Schmiegelow K,  Brok JS, Wadt KAW. Germline (epi)genetics reveals high predisposition in females: a 5-year, nationwide, prospective Wilms tumour cohort. J Med Genet 2023, 60: 842-9. https://doi.org/10.1136/jmg-2022-108982

Søegaard SH, Spanggaard M, Rostgaard K, Kamper-Jørgensen M, Stensballe LG, Schmiegelow K, Hjalgrim H. Childcare attendance and risk of infections in childhood and adolescence. Int J Epidemiol 2023; 52: 466-75. https://doi.org/10.1093/ije/dyac219

Østergaard A, Enshaei A, Vora A, Horstmann M, Escherich G, Johansson B, Heyman M, Schmiegelow K, Hoogerbrugge P, Pieters R, den Boer M, Kuiper R, Moorman A, Boer J, van Leeuwen F. The prognostic effect of IKZF1 deletions in ETV6::RUNX1 and high hyperdiploid childhood acute lymphoblastic leukemia. HaemaSphere 2023; 7: e875. https://doi.org/10.1097/hs9.0000000000000875

Arad-Cohen N, Zeller B, Abrahamsson J, Fernandez Navarro JM, Cheuk D, Palmu S, Costa V, De Moerloose B, Hasle H, Jahnukainen K, Pronk CJ, Gísli Jónsson Ó, Kovalova Z, Lausen B, Munthe-Kaas M, Noren-Nyström U, Palle J, Pasauliene R, Saks K, Kaspers GJ. Supportive care in pediatric acute myeloid leukemia:expert-based recommendations of the NOPHO-DB-SHIP consortium. Expert Review of Anticancer Therapy 2022 Nov;22(11): 1183-1196. https://doi.org/10.1080/14737140.2022.2131544 Epub 2022 Oct 28.

Benetton M, Merli P, Walter C, Hansen M, Da Ros A, Polato K, Tregnago C, Abrahamsson J, Strocchio L, Sonneveld E, Fogelstrand L, Von Neuhoff N, Reinhardt D, Hasle H, Pigazzi M, Locatelli F. Molecular Measurable Residual Disease Assessment before Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia Patients: A Retrospective Study by the I-BFM Study Group. Biomedicines 2022 Jun 28;10(7):1530. https://doi.org/10.3390/biomedicines10071530

Bertrums EJM, Zwaan CM, Hasegawa D, De Haas V, Reinhardt DN, Locatelli F, De Moerloose B, Dworzak M, Buijs A, Smisek P, Kolenova A, Pronk CJ, Klusmann JH, Carboné A, Ferster A, Antoniou E, Meshinchi S, Raimondi SC, Niemeyer CM, Hasle H, Van den Heuvel-Eibrink MM, Goemans BF. Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS. Haematologica 2022 Mar 1; 107(3): 759-764. https://doi.org/10.3324/haematol.2021.279507

Borgstedt-Bendixen SE, Abrahamsson J, Ha SY, Koskenvuo M, Lausen B, Palle J, Zeller B, Hasle H, Løhmann DJA. Abdominal Complications During Treatment for Pediatric Acute Myeloid Leukemia. Journal of Pediatric Hematology Oncology 2022 Jul 1; 44(5): 220-229. https://doi.org/10.1097/mph.0000000000002281 Epub 2021 Aug 16.

Brix N, Amstrup J, Nørgaard M, Hagstrøm S, Hasle H, Herlin T. Musculoskeletal Diagnoses Prior to Cancer in Children: A Danish Registry-Based Cohort Study. Journal of Pediatrics 2022 Mar; 242:32-38.e2. https://doi.org/10.1016/j.jpeds.2021.11.024 Epub 2021 Nov 17.

Brix N, Glerup M, Thiel S, Mistergaard CE, Skals RG, Berntson L, Fasth A, Nielsen, Nordal E, Rygg M, Hasle H, Albertsen BK, Herlin T. M-ficolin: a valuable biomarker to identify leukemia from juvenile idiopathic arthritis. Archives of Disease in Childhood 2022 Apr; 107(4): 371-376. https://doi.org/10.1136/archdischild-2021-322114 Epub 2021 Oct 22.

Degn K, Beltrame L, Dahl Hede F, Sora V, Nicolaci V, Vabistsevits M, Schmiegelow K, Wadt K, Tiberti M, Lambrughi M, Papaleo E. Cancer-related Mutations with Local or Long-range Effects on an Allosteric Loop of p53. J Mol Biol. 2022 Sep 15;434(17):167663. https://doi.org/10.1016/j.jmb.2022.167663 Epub 2022 May 31.

Foss-Skiftesvik J, Stoltze UK, van Overeem Hansen T, Ahlborn LB, Sørensen E, Ostrowski SR, Kullegaard SMA, Laspiur AO, Melchior LC, Scheie D, Kristensen BW, Skjøth-Rasmussen J, Schmiegelow K, Wadt K, Mathiasen R. Redefining germline predisposition in children with molecularly characterized ependymoma: a population-based 20-year cohort. Acta Neuropathol Commun. 2022 Aug 25;10(1):123. https://doi.org/10.1186/s40478-022-01429-1

Frederiksen LE, Pedersen C, Mogensen H, Mader L, Bautz A, Talbäck M, Hirvonen E, Norsker FN, Hasle H, Malila N, Madanat-Harjuoja L, Feychting M, Erdmann F, Winther JF. Employment status and occupational positions of childhood cancer survivors from Denmark, Finland and Sweden: A Nordic register-based cohort study from the SALiCCS research programme. Lancet Regional Health Europe 2021 Nov 30;12:100258. eCollection 2022 Jan. https://doi.org/10.1016/j.lanepe.2021.100258

Frederiksen LE, Erdmann F, Mader L, Mogensen H, Pedersen C, Kenborg L, Bautz A, Talbäck M, Hirvonen E, Nielsen TJ, Andersen EAW, Holmqvist AS, Jørgensen OS, Jepsen JRM, Malila N, Hasle H, Madanat-Harjuoja L, Feychting M, Winther JF. Psychiatric disorders in childhood cancer survivors in Denmark, Finland and Sweden: A Nordic register-based cohort study from the SALiCCS research programme. The Lancet Psychiatry 2022; 9(1): 35-45. https://doi:10.1016/S2215-0366(21)00387-4   Epub 2021 Nov 22.

Hasle H, Kline RM, Kjeldsen E, Nik-Abdul-Rashid NF, Bhojwani D, Verboon JM, DiTroia SP, Chao KR, Raaschou-Jensen K, Palle J, Zwaan CM, Nyvold CG, Sankaran VG, Cantor AB. Germline GATA1s generating mutations predispose to leukemia with acquired trisomy 21 and Down syndrome-like phenotype. Blood 2022 May 26; 139(21): 3159-3165. https://doi.org/10.1182/blood.2021011463

Helenius M, Vaitkeviciene G, Abrahamsson J, Jonsson ÓG, Lund B, Harila-Saari A, Vettenranta K, Mikkel S, et al. Characteristics of white blood cell count in acute lymphoblastic leukemia: A COST LEGEND phenotype–genotype study. Pediatr Blood Cancer. 2022 Mar 22;69(7):e29582. https://doi.org/10.1002/pbc.29582

Helligsø ASL, Kenborg L, Henriksen LT, Udupi A, Hasle H, Winther JF. Incidence and survival of childhood central nervous system tumors in Denmark, 1997-2019. Cancer Medicine 2022 Jan; 11(1): 245-256. https://doi.org/10.1002/cam4.4429 Epub 2021 Nov 19.

Høgsholt S, Asdahl PH, Rechnitzer C, Winther JF, Birn H, Hasle H. Kidney disease in very long-term survivors of Wilms tumor: A nationwide cohort study with sibling controls. Cancer Medicine 2023 Jan; 12(2): 1330-1338. https://doi.org/10.1002/cam4.5010 Epub 2022 Jul 16.

Jensen MR, Stoltze U, Hansen TVO, Bak M, Sehested A, Rechnitzer C, Mathiasen R, Scheie D, Larsen KB, Olsen TE, Muhic A, Skjøth-Rasmussen J, Rossing M, Schmiegelow K, Wadt K. 9p21.3 Microdeletion involving CDKN2A/2B in a young patient with multiple primary cancers and review of the literature. Cold Spring Harb Mol Case Stud. 2022 Jun 22;8(4):a006164. https://doi.org/10.1101/mcs.a006164

Fogelstrand L., Karlsson L., Nyvold C.G., Soboli A., Johansson P., Palmqvist L., Tierens A., Hasle H., Lausen B., Jónsson Ó.G., Jürgensen G.W., Ebbesen L.H., Abrahamsson J. Fusion transcript analysis reveals slower response kinetics than multiparameter flow cytometry in childhood acute myeloid leukemia. International Journal of Laboratory Hematology 2022 Dec; 44(6): 1094-1101. https://doi.org/10.21203/rs.3.rs-1474309/v1 Epub 2022 Aug 2.

Klein K, Beverloo HB, Zimmermann M, Raimondi SC, von Neuhoff C, de Haas V, van Weelderen R, Cloos J, Abrahamsson J, Bertrand Y, Dworzak M, Fynn A, Gibson B, Ha SY, Harrison CJ, Hasle H, Elitzur S, Leverger G, Maschan A, Razzouk B, Reinhardt D, Rizzari C, Smisek P, Creutzig U, Kaspers GJL. Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia: A retrospective cohort study of the Relapsed AML 2001/01 Study. Pediatric Blood & Cancer. 2022 Jan; 69(1): e29341. https://doi.org/10.1002/pbc.29341 Epub 2021 Sep 17.

Kløve-Mogensen K, Steffensen R, Masmas TN, Glenthøj A, Haunstrup TM, Ratcliffe P, Höglund P, Hasle H, Nielsen KR. ABO, secretor, and Lewis carbohydrate histo-blood groups are associated with autoimmune neutropenia of early childhood in Danish patients. Transfusion 2022 Aug; 62(8): 1636-1642. https://doi.org/10.1111/trf.17002 Epub 2022 Jul 6.

Niemeyer CM, Rudelius M, Shimamura A, Flotho C, Hasle H, Stieglitz E, Strahm B, Godley LA, Weinberg OK, Orazi A, Calvo KR. Classification of rare pediatric myeloid neoplasia-Quo vadis? Leukemia 2022 Dec; 36(12): 2947-1948. https://doi:10.1038/s41375-022-01731-w  Epub 2022 Oct 21.

Nissen IB, Handrup MM, Bang K, Hasle H. Glucocorticosteroid and Silicone Gel During Patch Application Without Clinical Scar Improvement After Central Venous Catheter Removal: A Randomized Trial. Journal of Pediatric Hematology Oncology 2022 Oct 1;44(7): e988-93. https://doi.org/10.1097/mph.0000000000002517 Epub 2022 Aug 5.

Petersen MA, Rosenberg CA, Bill M, Enemark MB, Rahbek O, Roug AS, Hasle H, Honoré B, Ludvigsen M. Proteomic profiling identifies specific leukemic stem cell-associated protein expression patterns in pediatric AML patients. Cancers 2022 Jul 22; 14(15): 3567. https://doi.org/10.3390/cancers14153567

Petersen MA, Rosenberg CA, Brøndum RF, Aggerholm A, Kjeldsen E, Rahbek O, Ludvigsen M, Hasle H, Roug AS, Bill M. Immunophenotypically defined stem cell subsets in paediatric AML are highly heterogeneous and demonstrate differences in BCL-2 expression by cytogenetic subgroups. British Journal of Haematology 2022 May; 197(4): 452-466. https://doi.org/10.1111/bjh.18094   Epub 2022 Mar 17.

Pfister SM, Reyes-Múgica M, Chan JKC, Hasle H, Lazar AJ, Rossi S, Ferrari A, Jarzembowski JA, Pritchard-Jones K, Hill DA, Jacques TS, Wesseling P, López Terrada DH, von Deimling A, Kratz CP, Cree IA, Alaggio R. A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era. Cancer Discovery 2022 Feb; 12(2): 331-355. https://doi.org/10.1158/2159-8290.cd-21-1094 Epub 2021 Dec 17

Schmidt-Andersen P, Fridh MK, Müller KG, Anna Pouplier, Hjalgrim LL, Faigenbaum AD, Schmiegelow K, Hasle H, Lykkedegn S, Zhang H, Christensen J, Larsen HB. Integrative Neuromuscular Training in Adolescents and Children Treated for Cancer (INTERACT): Study Protocol for a Multicenter, Two-Arm Parallel-Group Randomized Controlled Superiority Trial. Front. Pediatr. 2022 Mar 14:10:833850. https://doi.org/10.3389/fped.2022.833850  eCollection 2022.

Sora V, Otamendi Laspiur A, Degn K, Arnaudi M, Utichi M, Beltrame L, De Menezes D, Orlandi M, Stoltze UK, Rigina O, Sackett PW, Wadt K, Schmiegelow K, Tiberti M, Papaleo E. Rosetta DDG Prediction for high-throughput mutational scans: from stability to binding. Protein Sci. 2023 Jan;32(1):e4527. https://doi.org/10.1002/pro.4527 Epub 2022 Dec 3.

Stoltze UK, Foss Skiftesvik J, van Overeem Hansen T, Byrjalsen A, Sehested A, Scheie D, Mikkelsen TS, Rasmussen S, Bak M, Okkels H, Callesen MT, Skjøth Rasmussen J, Gerdes AM, Schmiegelow K, Mathiasen R, Wadt K. Genetic predisposition and evolutionary traces of pediatric cancer risk: a prospective 5 year population-based genome sequencing study of children with CNS tumors. Neuro-Oncology. 2023 Apr;25(4):761–773. Epub 2022 Jul 29. https://doi.org/10.1093/neuonc/noac187

Stoltze UK, Foss Skiftesvik J, van Overeem Hansen T, Byrjalsen A, Sehested A, Scheie D, Mikkelsen TS, Rasmussen S, Bak M, Okkels H, Callesen MT, Skjøth Rasmussen J, Gerdes AM, Schmiegelow K, Mathiasen R, Wadt K. Population-based whole genome sequencing with constrained gene analysis identifies predisposing germline variants in children with central nervous system tumors. medRxiv [Preprint]. 2022 Mar 8; https://doi.org/10.1101/2022.03.01.22271578

Stoltze UK, Hansen TVO, Brok JS, Grønskov K, Tumer AZ, Ahlborn LB, Schmiegelow K, Wadt KAW. Maternal versus paternal inheritance of a 132 bp 11p15.5 microdeletion affecting KCNQ1OT1 and associated phenotypes. J Med Genet. 2023 Feb;60(2):128-130. https://doi.org/10.1136/jmedgenet-2021-108335 Epub 2022 Jun 30.

Sørensen GV, Albieri V, Holmqvist AS, Erdmann F, Mogensen H, Talbäck M, Ifversen M, Lash TL, Feychting M, Schmiegelow K, Heyman MM, Winther JF, Hasle H. Long-Term Risk of Hospitalization for Somatic Diseases Among Survivors of Childhood Acute Lymphoblastic Leukemia. JNCI Cancer Spectrum 2022 Mar 2;6(2):pkac029. https://doi.org/10.1093/jncics/pkac029

Sørensen GV, Belmonte F, Erdmann F, Mogensen H, Albieri V, Holmqvist AS, Madanat-Harjuoja L, Talbäck M, Heyman MM, Malila N, Feychting M, Schmiegelow K, Winther JF, Hasle H. Late mortality among survivors of childhood acute lymphoblastic leukemia diagnosed during 1971-2008 in Denmark, Finland, and Sweden: A population-based cohort study. Pediatric Blood & Cancer 2022 Jan; 69(1): https://doi.org/10.1002/pbc.29356

White T, Kaspers G, Abrahamsson J, Arad-Cohen N, Cianci D, Fernandez J, Ha SY, Hasle H, De Moerloose B, Zwaan CM, Goemans BF. Clinical outcomes of second relapsed and refractory first relapsed paediatric AML: A retrospective study within the NOPHO-DB SHIP consortium. British Journal of Haematology 2022 Jan; 197(6): 755-765. https://doi.org/10.1111/bjh.18039 Epub 2022 Feb 4.

Andrés-Jensen L, Attarbaschi A, Bardi E, Barzilai-Birenboim S, Bhojwani D, Hagleitner MM, Halsey C, Harila-Saari A, van Litsenburg RRL, Hudson MM, Jeha S, Kato M, Kremer L, Mlynarski W, Möricke A, Pieters R, Piette C, Raetz E, Ronceray L, Toro C, Grazia Valsecchi M, Vrooman LM, Weinreb S, Winick N, Schmiegelow K; Ponte di Legno Severe Toxicity Working Group. Severe toxicity free survival: physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemia. Lancet Haematol. 2021 Jul;8(7):e513-e523. https://doi.org/10.1016/s2352-3026(21)00136-8

Andrés-Jensen L, Skipper MT, Mielke Christensen K, Hedegaard Johnsen P, Aagaard Myhr K, Kaj Fridh M, Grell K, Pedersen AML, Leisgaard Mørck Rubak S, Ballegaard M, Hørlyck A, Beck Jensen R, Lambine TL, Gjerum Nielsen K, Tuckuviene R, Skov Wehner P, Klug Albertsen B, Schmiegelow K, Frandsen TL. National, clinical cohort study of late effects among survivors of acute lymphoblastic leukaemia: the ALL-STAR study protocol. BMJ Open. 2021 Feb 9;11(2):e045543. https://doi.org/10.1136/bmjopen-2020-045543

Asdahl PH, Oeffinger KC, Albieri V, Hudson M, Leisenring WM, Donaldson SS, Hasle H, Winther JF, Armstrong GT, Robison LL. Esophageal disease among childhood cancer survivors-A report from the Childhood Cancer Survivors Study. Pediatric Blood & Cancer 2021 Aug; 68(8):e29043. https://doi.org/10.1002/pbc.29043 Epub 2021 Apr 12.

Bakhuizen JJ, Hanson H, van der Tuin K, Lalloo F, Tischkowitz M, Wadt K, Jongmans MCJ; SIOPE Host Genome Working Group; CanGene-CanVar Clinical Guideline Working Group; Expert Network Members. Surveillance recommendations for DICER1 pathogenic variant carriers: a report from the SIOPE Host Genome Working Group and CanGene-CanVar Clinical Guideline Working Group. Fam Cancer. 2021 Oct;20(4):337-348. https://doi.org/10.1007/s10689-021-00264-y Epub 2021 Jun 25.

Bortnick R, Wlodarski M, de Haas V, De Moerloose B, Dworzak M, Hasle H, Masetti R, Stary J, Turkiewicz D, Ussowicz M, Kozyra E, Albert M, Bader P, Bordon V, Cario G, Beier R, Schulte J, Bresters D, Müller I, Pichler H, Sedlacek P, Sauer MG, Zecca M, Göhring G, Yoshimi A, Noellke P, Erlacher M, Locatelli F, Niemeyer CM, Strahm B; for EWOG-MDS. Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome. Bone Marrow Transplantation 2021 Nov; 56(11): 2732-2741. https://doi.org/10.1038/s41409-021-01374-y Epub 2021 Jul 9.

Erdmann F, Frederiksen LE, Mogensen H, Pedersen C, Mader L, Talbäck M, Bautz A, Hirvonen E, Kyrönlahti A, Korhonen LM, Hasle H, Malila N, Madanat-Harjuoja LM, Feychting M, Winther JF. Cohort Profile: The Socioeconomic Consequences in Adult Life After Childhood Cancer in Scandinavia (SALiCCS) Research Programme. Frontiers in Oncology 2021 Nov 26;11:752948. https://doi.org/10.3389/fonc.2021.752948  eCollection 2021.

Erdmann F, Frederiksen LE, Bonaventure A, Mader L, Hasle H, Robison LL, Winther JF. Childhood cancer: Survival, treatment modalities, late effects and improvements over time. Cancer Epidemiology 2021 Apr; 71(Pt B): 101733. https://doi.org/10.1016/j.canep.2020.101733 Epub 2020 May 24.

de Fine Licht S, Rugbjerg K, Andersen EW, Nielsen TT, Norsker FN, Kenborg L, Holmqvist AS, Madanat-Harjuoja LM, Tryggvadottir L, Stovall M, Wesenberg F, Hjorth L, Hasle H, Winther JF. Temporal changes in the probability of live birth among female survivors of childhood cancer: A Population-Based Adult Life After Childhood Cancer in Scandinavia (ALiCCS) study in five Nordic countries. Cancer 2021; 127(20): 3881-3892. https://doi.org/10.1530/ey.19.9.8 Epub 2021 Jul 23.

Fornerod M, Ma J, Noort S, Liu Y, Walsh MP, Shi L, Nance S, Liu Y, Wang Y, Song G, Lamprecht T, Easton J, Mulder HL, Yergeau D, Myers J, Kamens JL, Obeng EA, Pigazzi M, Jarosova M, Kelaidi C, Polychronopoulou S, Lamba JK, Baker SD, Rubnitz JE, Reinhardt D, van den Heuvel-Eibrink MM, Locatelli F, Hasle H, Klco JM, Downing JR, Zhang J, Pounds S, Zwaan CM, Gruber TA. Integrative Genomic Analysis of Pediatric Myeloid-Related Acute Leukemias Identifies Novel Subtypes and Prognostic Indicators. Blood Cancer Discovery 2021 Sep 9; 2(6): 586-599 https://doi.org/10.1158/2643-3230.bcd-21-0049 eCollection 2021 Nov.

Heeney MM, Berhe S, Campagna DR, Oved JH, Kurre P, Shaw PJ, Teo J, Shanap MA, Hassab HM, Glader BE, Shah S, Yoshimi A, Ameri A, Antin JH, Boudreaux J, Briones M, Dickerson KE, Fernandez CV, Farah R, Hasle H, Keel SB, Olson TS, Powers JM, Rose MJ, Shimamura A, Bottomley SS, Fleming MD. SLC25A38 Congenital Sideroblastic Anemia: Phenotypes and genotypes of 31 individuals from 24 families, including 11 novel mutations, and a review of the literature. Human Mutation 2021 Now; 42(11): 1367-1383. https://doi.org/10.1002/humu.24267  Epub 2021 Aug 5.

Helligsø ASL, Henriksen LT, Kenborg L, Dehlendorff C, Winther JF, Hasle H. Factors influencing participation rates in clinical late-effect studies of childhood cancer survivors. Pediatric Blood & Cancer  2021 Sep; 68(9): e29098. https://doi.org/10.1002/pbc.29098 Epub 2021 May 22

Herlin MK, Yones SA, Kjeldsen E, Holmfeldt L, Hasle H. What Is Abnormal in Normal Karyotype Acute Myeloid Leukemia in Children? Analysis of the Mutational Landscape and Prognosis of the TARGET-AML Cohort. Genes (Basel) 2021 May 21; 12(6): 792. https://doi.org/10.3390/genes12060792

Høgsholt S, Asdahl PH, Bonnesen TG, Holmqvist AS, Madanat-Harjuoja L, Tryggvadottir L, Bautz A, Albieri V, Green D, Winther JF, Hasle H. Disease specific hospitalizations among 5-year survivors of Wilms tumor: A Nordic population-based cohort study. Pediatric Blood & Cancer 2021 May; 68(5): e28905. doi: 10.1002/pbc.28905. Epub 2021 Jan 23. https://doi.org/10.1002/pbc.28905

Kozyra EJ, Gohring G, Hickstein DD, Calvo KR, DiNardo CD, Dworzak M, de Haas V, Stary J, Hasle H, Shimamura A, Fleming MD, Inaba H, Lewis S, Hsu AP, Holland SM, Arnold DE, Mecucci C, Keel SB, Bertuch AA, Tawana K, Barzilai-Birenboim S, Hirabayashi S, Onozawa M, Lei S, Alaiz H, Andrikovics H, Betts D, Beverloo HB, Buechner J, Čermák M, Cervera J, Haus O, Jahnukainen K, Manola K, Nebral K, Pasquali F, Tchinda J, Turkiewicz D, Van Roy N, Zemanova Z, Pastor VB, Strahm B, Nöllke P, Niemeyer CM, Schlegelberger B, Yoshimi A, Wlodarski MW. Association of Unbalanced Translocation der(1;7) with Germline GATA2 Mutations. Blood 2021 Dec 9; 138(23): 2441-2445. https://doi.org/10.1182/blood.2021012781

Krali O, Palle J, Bäcklin CL, Abrahamsson J, Norén-Nyström U, Hasle H, Jahnukainen K, Jónsson ÓG, Hovland R, Lausen B, Larsson R, Palmqvist L, Staffas A, Zeller B, Nordlund J. DNA Methylation Signatures Predict Cytogenetic Subtype and Outcome in Pediatric Acute Myeloid Leukemia (AML). Genes (Basel) 2021 Jun 10; 12(6): 895. https://doi.org/10.3390/genes12060895

Meijer AJM, Diepstraten FA, Langer T, Broer L, Domingo IK, Clemens E, Uitterlinden AG, de Vries ACH, van Grotel M, Vermeij WP, Ozinga RA, Binder H, Byrne J, van Dulmen-den Broeder E, Garrè ML, Grabow D, Kaatsch P, Kaiser M, Kenborg L, Winther JF, Rechnitzer C, Hasle H, Kepak T, Kepakova K, Tissing WJE, van der Kooi ALF, Kremer LCM, Kruseova J, Pluijm SMF, Kuehni CE, van der Pal HJH, Parfitt R, Spix C, Tillmanns A, Deuster D, Matulat P, Calaminus G, Hoetink AE, Elsner S, Gebauer J, Haupt R, Lackner H, Blattmann C, Neggers SJCMM, Rassekh SR, Wright GEB, Brooks B, Nagtegaal AP, Drögemöller BI, Ross CJD, Bhavsar AP, Am Zehnhoff-Dinnesen AG, Carleton BC, Zolk O, van den Heuvel-Eibrink MM; PanCareLIFE Consortium; and the CPNDS Consortium. TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study. NPJ Precision Oncology 2021 Jul 14;5(1):64. https://doi.org/10.1038/s41698-021-00178-z

Oskarsson T, Duun-Henriksen AK, Bautz A, Montgomery S, Harila-Saari A, Petersen C, Niinimäki R, Madanat-Harjuoja L, Tryggvadóttir L, Holmqvist AS, Hasle H, Heyman M, Winther JF. Skeletal adverse events in childhood cancer survivors: An Adult Life after Childhood Cancer in Scandinavia (ALiCCS) cohort study. International Journal of Cancer 2021 Dec 1; 149(11): 1863-1876. doi: 10.1002/ijc.33741. Epub 2021 Jul 30. https://doi.org/10.1002/ijc.33741

Pedersen C, Rechnitzer C, Andersen EAW, Kenborg L, Norsker FN, Bautz A, Baad-Hansen T, Tryggvadottir L, Madanat-Harjuoja LM, Holmqvist AS, Hjorth L, Hasle H, Winther JF, On behalf of the ALiCCS Study Group. Somatic Disease in Survivors of Childhood Malignant Bone Tumors in the Nordic Countries. Cancers (Basel) 2021 Sep 7; 13(18): 4505. https://doi.org/10.3390/cancers13184505

Pedersen LH, Winther JF, Gammelager H, Nørgaard M, Schmiegelow K, Sletner CB, Hasle H, Ehrenstein V. Socioeconomic position and prediagnostic health care contacts in children with cancer in Denmark: a nationwide register study. BMC Cancer. 2021 Oct 14;21(1):1104. https://doi.org/10.1186/s12885-021-08837-x

Pedersen LH, Østergaard A, Bank V, Nersting J, Tuckuviene R, Wehner PS, Albertsen BK, Degn M, Als-Nielsen BET, Larsen HB, Schmiegelow K, Dalton SO. Socioeconomic position and maintenance therapy in children with acute lymphoblastic leukemia: A national cohort study. Pediatr Blood Cancer. 2022 Jul;69(7):e29508. doi: 10.1002/pbc.29508. Epub 2021 Dec 21. https://doi.org/10.1002/pbc.29508

Sahoo SS, Pastor VB, Goodings C, Voss RK, Kozyra EJ, Szvetnik A, Noellke P, Dworzak M, Starý J, Locatelli F, Masetti R, Schmugge M, De Moerloose B, Catala A, Kállay K, Turkiewicz D, Hasle H, Buechner J, Jahnukainen K, Ussowicz M, Polychronopoulou S, Smith OP, Fabri O, Barzilai S, de Haas V, Baumann I, Schwarz-Furlan S; European Working Group of MDS in Children (EWOG-MDS), Niewisch MR, Sauer MG, Burkhardt B, Lang P, Bader P, Beier R, Müller I, Albert MH, Meisel R, Schulz A, Cario G, Panda PK, Wehrle J, Hirabayashi S, Derecka M, Durruthy-Durruthy R, Göhring G, Yoshimi-Noellke A, Ku M, Lebrecht D, Erlacher M, Flotho C, Strahm B, Niemeyer CM, Wlodarski MW. Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes. Nature Medicine 2021 Oct;27(10): 1806-1817. doi: 10.1038/s41591-021-01511-6. Epub 2021 Oct 7. https://doi.org/10.1038/s41591-021-01511-6

Salem H, Kazak AE, Andersen EW, Belmonte F, Johansen C, Schmiegelow K, Winther JF, Wehner PS, Hasle H, Rosthøj S, Bidstrup PE. Home-based cognitive behavioural therapy for families of young children with cancer (FAMOS): A nationwide randomised controlled trial. Pediatric Blood & Cancer 2021 Mar; 68(3); e28853. doi: 10.1002/pbc.28853. Epub 2020 Dec 27. https://doi.org/10.1002/pbc.28853

Skou AS, Juul-Dam KL, Hansen M, Lausen B, Stratmann S, Holmfeldt L, Aggerholm A, Nyvold CG, Ommen HB, Hasle H. Measurable residual disease monitoring of SPAG6, ST18, PRAME, and XAGE1A expression in peripheral blood may detect imminent relapse in childhood acute myeloid leukemia. Journal of Molecular Diagnostics 2021; Dec;23(12): 1787-1799. doi: 10.1016/j.jmoldx.2021.09.004. Epub 2021 Sep 29. https://doi.org/10.1016/j.jmoldx.2021.09.004

Skou AS, Juul-Dam KL, Ommen HB, Hasle H. Peripheral blood molecular measurable residual disease is sufficient to identify patients with acute myeloid leukaemia with imminent clinical relapse. British Journal of Haematology 2021 Nov;195(3): 310-327. doi: 10.1111/bjh.17449. Epub 2021 Apr 13. https://doi.org/10.1111/bjh.17449

Wilhelmsson M, Wilhelmsson M, Jahnukainen K, Winiarski J, Abrahamsson J, Bautz A, Gudmundsdottir T, Madanat-Harjuoja L, Holmqvist AS, Winther JF, Hasle H. Hospitalizations in Long-term Survivors of Childhood AML Treated with Allogeneic HCT – an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) Study. American Journal of Hematology  2021 Mar 1;96(3): E74-77. doi: 10.1002/ajh.26071. Epub 2021 Jan 28. https://doi.org/10.1002/ajh.26071

de Winter DTC, Langerak AW, Te Marvelde J, Dworzak MN, De Moerloose B, Stary J, Locatelli F, Hasle H, de Vries ACH, Schmugge M, Niemeyer CM, van den Heuvel-Eibrink MM, van der Velden VHJ. The variable biological signature of refractory cytopenia of childhood (RCC), a retrospective EWOG-MDS study. Leukemia Research 2021 Sep; 108: 106652. doi: 10.1016/j.leukres.2021.106652. Epub 2021 Jun 29. https://doi.org/10.1016/j.leukres.2021.106652

Anastasopoulou S, Heyman M, Eriksson MA, et al. Seizures during treatment of childhood acute lymphoblastic leukemia: A population-based cohort study. European journal of paediatric neurology. 2020 Jul;27:72-77. doi: 10.1016/j.ejpn.2020.04.004. Epub 2020 Apr 18. https://doi.org/10.1016/j.ejpn.2020.04.004

Andrés-Jensen L, Larsen HB, Johansen C, et al. Everyday life challenges among adolescent and young adult survivors of childhood acute lymphoblastic leukemia: An in-depth qualitative study. Psycho-oncology. 2020 Oct;29(10):1630-1637. doi: 10.1002/pon.5480. Epub 2020 Sep 9. https://doi.org/10.1002/pon.5480

Bache I, Wadt K, Mehrjouy MM, et al. A shared somatic translocation involving CUX1 in monozygotic twins as an early driver of AMKL in Down syndrome. Blood cancer journal. 2020 Mar 3;10(3):27. https://doi.org/10.1038/s41408-020-0293-6

Brandão LR, Albisetti M, Halton J, et al. Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children. Blood. 2020 Feb 13;135(7):491-504. https://doi.org/10.1182/blood.2019000998

Brix N, Rosthøj S, Glerup M, Hasle H, Herlin T. Identifying acute lymphoblastic leukemia mimicking juvenile idiopathic arthritis in children. PLoS One 2020 Aug 11; 15(8): e0237530. doi: 10.1371/journal.pone.0237530. eCollection 2020. https://doi.org/10.1371/journal.pone.0237530

Byrjalsen A, Stoltze UK, Castor A, et al. Germline whole genome sequencing in pediatric oncology in Denmark-Practitioner perspectives. Molecular genetics & genomic medicine. 2020 Aug;8(8):e1276. doi: 10.1002/mgg3.1276. Epub 2020 Jun 4. https://doi.org/10.1002/mgg3.1276

Byrjalsen A, Byrjalsen A, Hansen TVO, Stoltze UK, Mehrjouy MM, Barnkob NM, Hjalgrim LL, Mathiasen R, Lautrup CK, Gregersen PA, Hasle H, Wehner PS, Tuckuviene R, Sackett PW, Laspiur AO, Rossing M, Marvig RL, Tommerup N, Olsen TE, Scheie D, Gupta R, Gerdes AM, Schmiegelow K, Wadt K. Nationwide germline whole genome sequencing of 198 consecutive pediatric cancer patients reveals a high frequency of cancer prone syndromes. PLOS Genetics 2020 Dec 17;16(12): e1009231, doi: 10.1371/journal.pgen.1009231. eCollection 2020 Dec. https://doi.org/10.1038/s41397-019-0113-1

Clemens E, Broer L, Langer T, Uitterlinden AG, de Vries ACH, van Grotel M, Pluijm SFM, Binder H, Byrne J, Broeder EVD, Crocco M, Grabow D, Kaatsch P, Kaiser M, Kenborg L, Winther JF, Rechnitzer C, Hasle H,  Kepak T, van der Kooi AF, Kremer LC, Kruseova J, Kuehni CE, van der Pal H, Parfitt R, Deuster D, Matulat P, Spix C, Tillmanns A, Tissing WJE, Maier L, Am Zehnhoff-Dinnesen A, Zolk O, van den Heuvel-Eibrink MM, PanCareLIFE consortium.. Genetic Variation of Cisplatin-induced Ototoxicity in Non-cranial-irradiated Pediatric Patients Using a Candidate Gene Approach: The International PanCareLIFE Study. The Pharmacogenomics Journal 2020 Apr; 20(2): 294-305. doi: 10.1038/s41397-019-0113-1. Epub 2019 Oct 31. https://doi.org:10.1038/s41397-019-0113-1

De Pietri S, Ingham AC, Frandsen TL, Rathe M, Krych L, Castro Mejia JL, Nielsen DS, Nersting J, Wehner PS, Schmiegelow K, Hasle H, Pamp SJ, Müller K. Gastrointestinal toxicity during induction treatment for childhood acute lymphoblastic leukemia: the impact of the gut microbiota. International Journal of Cancer 2020 Oct 1; 147 (7): 1953-1962. doi: 10.1002/ijc.32942. Epub 2020 Mar 16. https://doi.org/10.1002/ijc.32942

Djursby M, Wadt K, Frederiksen JH, et al. A rare missense variant in APC interrupts splicing and causes AFAP in two Danish families. Hereditary cancer in clinical practice. 2020 Apr 7;18:8. doi: 10.1186/s13053-020-00140-3. eCollection 2020. https://doi.org/10.1186/s13053-020-00140-3

Ebbesen M, Enevold C, Juul A, et al. Insulin-Like Growth Factor Gene Polymorphisms Predict Clinical Course in Allogeneic Hematopoietic Stem Cell Transplantation. Frontiers in immunology. 2020 Jul 24;11:1646. doi: 10.3389/fimmu.2020.01646. eCollection 2020. https://doi.org/10.3389/fimmu.2020.01646

Eliasen A, Abildtoft MK, Krogh NS, et al. Smartphone App to Self-Monitor Nausea During Pediatric Chemotherapy Treatment: User-Centered Design Process. JMIR mHealth and uHealth. 2020 Jul 20;8(7):e18564. https://doi.org/10.2196/18564

Eliasen A, Dalhoff K, Mathiasen R, et al. Pharmacogenetics of antiemetics for chemotherapy-induced nausea and vomiting: A systematic review and meta-analysis. Critical reviews in oncology/hematology. 2020 May;149:102939. doi: 10.1016/j.critrevonc.2020.102939. Epub 2020 Apr 4. https://doi.org/10.1016/j.critrevonc.2020.102939

Enshaei A, O’Connor D, Bartram J, et al. A validated novel continuous prognostic index to deliver stratified medicine in pediatric acute lymphoblastic leukemia. Blood. 2020 Apr 20;135(17):1438-1446. https://doi.org/10.1182/blood.2019003191

Grønbæk J, Keating R, Wisoff J, et al. Introduction to the cerebellar mutism syndrome. Child’s nervous system: ChNS: official journal of the International Society for Pediatric Neurosurgery. 2020;36(6):1143-1144. doi: 10.1007/s00381-019-04298-7. Epub 2019 Aug 9. https://doi:10.1007/s00381-019-04298-7

Grønbæk J, Molinari E, Avula S, et al. The supplementary motor area syndrome and the cerebellar mutism syndrome: a pathoanatomical relationship? Child’s nervous system: ChNS: official journal of the International Society for Pediatric Neurosurgery. 2020 Jun;36(6):1197-1204. doi: 10.1007/s00381-019-04202-3. Epub 2019 May 24. https://doi:10.1007/s00381-019-04202-3

Haider Z, Landfors M, Golovleva I, et al. DNA methylation and copy number variation profiling of T-cell lymphoblastic leukemia and lymphoma. Blood cancer journal. 2020 Apr 28;10(4):45. https://doi.org/10.1038/s41408-020-0310-9

Hanghøj S, Pappot H, Hjalgrim LL, et al. Experiences of involvement processes during participation in cancer service user initiatives from an adolescent and young adult perspective. International journal of adolescent medicine and health. 2020 Jun 10,34(2):67-75.  https://doi.org/10.1515/ijamh-2019-0253

Hanghøj S, Pappot H, Hjalgrim LL, et al. Impact of Service User Involvement from the Perspective of Adolescents and Young Adults with Cancer Experience. Journal of adolescent and young adult oncology. 2020 Feb;9(1):78-84. doi: 10.1089/jayao.2019.0073. Epub 2019 Oct 4. https://doi.org/10.1089/jayao.2019.0073

Haugaard AK, Kofoed J, Masmas TN, et al. Is microchimerism a sign of imminent disease recurrence after allogeneic hematopoietic stem cell transplantation? A systematic review of the literature. Blood reviews. 2020 Nov;44:100673. doi: 10.1016/j.blre.2020.100673. Epub 2020 Feb 26. https://doi.org/10.1016/j.blre.2020.100673

Hrusak O, Kalina T, Wolf J, et al. Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment. European journal of cancer (Oxford, England : 1990). 2020 Jun; 132:11-16. doi: 10.1016/j.ejca.2020.03.021. Epub 2020 Apr 7. https://doi.org/10.1016/j.ejca.2020.03.021

Haavisto A, Mathiesen S, Suominen A, et al. Male Sexual Function after Allogeneic Hematopoietic Stem Cell Transplantation in Childhood: A Multicenter Study. Cancers. 2020;12(7). 1786. https://doi.org/10.3390/cancers12071786

Jarvis KB, Nielsen RL, Gupta R, et al. Polygenic risk score-analysis of thromboembolism in patients with acute lymphoblastic leukemia. Thrombosis research. 2020 Dec;196:15-20. doi: 10.1016/j.thromres.2020.08.015. Epub 2020 Aug 12. https://doi.org/10.1016/j.thromres.2020.08.015

Juul-Dam KL, Ommen HB, Nyvold CG, Walter C, Vålerhaugen H, Kairisto V, Abrahamsson J, Alm SJ, Jahnukainen K, Lausen B, Reinhardt D, Zeller B, von Neuhoff N, Fogelstrand L, Hasle H. Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemia. British Journal of Haematology 2020 Jul; 190(2): 198-208.  doi: 10.1111/bjh.16560. Epub 2020 Mar 16. https://doi.org/10.1111/bjh.16560

Kenborg L, Linnet KM, de Fine Licht S, Bautz A, Holmqvist AS, Tryggvadottir L, Madanat-Harjuoja LM, Stovall M, Heilmann C, Albieri V, Hasle H, Winther JF; ALiCCS study group. Hospital admission for neurologic disorders among five-year survivors of non-central nervous system tumors in childhood: a cohort study within the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study. International Journal of Cancer 2020 Feb 1; 146(3): 819-28. doi: 10.1002/ijc.32341. Epub 2019 Apr 29. https://doi: 10.1002/ijc.32341

Kozyra EJ, Pastor VB, Lefkopoulos S, Sahoo SS, Busch H, Voss RK, Erlacher M, Lebrecht D, Szvetnik EA, Hirabayashi S, Pasaulien? R, Pedace L, Tartaglia M, Klemann C, Metzger P, Boerries M, Catala A, Hasle H, de Haas V, Kállay K, Masetti R, De Moerloose B, Dworzak M, Schmugge M, Smith O, Star? J, Mejstrikova E, Ussowicz M, Morris E, Singh P, Collin M, Derecka M, Göhring G, Flotho C, Strahm B, Locatelli F, Niemeyer CM, Trompouki E, Wlodarski MW; European Working Group of MDS in Childhood (EWOG-MDS). Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency. Leukemia 2020 Oct; 34(10): 2673-2687. doi: 10.1038/s41375-020-0899-5. Epub 2020 Jun 18. https://doi.org/10.1038/s41375-020-0899-5

Langer T, Clemens E, Broer L, Maier L, Uitterlinden AG, de Vries ACH, van Grotel M, Pluijm SFM, Binder H, Mayer B, von dem Knesebeck A, Byrne J, van Dulmen-den Broeder E, Crocco M, Grabow D, Kaatsch P, Kaiser M, Spix C, Kenborg L, Winther JF, Rechnitzer C, Hasle H, Kepak T, van der Kooi AF, Kremer LC, Kruseova J, Bielack S, Sorg B, Hecker-Nolting S, Kuehni CE, Ansari M, Kompis M, van der Pal HJ, Parfitt R, Deuster D, Matulat P, Tillmanns A, Tissing WJE, Beck JD, Elsner S, Am Zehnhoff-Dinnesen A, van den Heuvel-Eibrink MM, Zolk O; PanCareLIFE consortium. Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset. Data in Brief 2020 Aug 24; 32: 106227. doi: 10.1016/j.dib.2020.106227. eCollection 2020 Oct. https://doi.org/10.1016/j.dib.2020.106227

Langer T, Clemens E, Broer L, Maier L, Uitterlinden AG, de Vries ACH, van Grotel M, Pluijm SFM, Binder H, Mayer B, von dem Knesebeck A, Byrne J, van Dulmen-den Broeder E, Crocco M, Grabow D, Kaatsch P, Kaiser M, Spix C, Kenborg L, Winther JF, Rechnitzer C, Hasle H, Kepak T, van der Kooi AF, Kremer LC, Kruseova J, Bielack S, Sorg B, Hecker-Nolting S, Kuehni CE, Ansari M, Kompis M, van der Pal H, Parfitt R, Deuster D, Matulat P, Tillmanns A, Tissing WJE, Beck JD, Elsner S, Am Zehnhoff-Dinnesen A, van den Heuvel-Eibrink MM, Zolk O; PanCareLIFE consortium. Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study. European Journal of Cancer 2020 Oct; 138: 212-224. doi: 10.1016/j.ejca.2020.07.019. Epub 2020 Sep 6. https://doi.org/10.1016/j.ejca.2020.07.019

Larsen RH, Hjalgrim LL, Grell K, et al. Pharmacokinetics of tablet and liquid formulations of oral 6-mercaptopurine in children with acute lymphoblastic leukemia. Cancer chemotherapy and pharmacology. 2020 Jul;86(1):25-32. doi: 10.1007/s00280-020-04097-x. Epub 2020 Jun 9. https://doi.org/10.1007/s00280-020-04097-x

Laumann RD, Iversen T, Mogensen PR, et al. Effect of Fish Oil Supplementation on Hyperlipidemia during Childhood Acute Lymphoblastic Leukemia Treatment – A Pilot Study. Nutrition and cancer. 2021: 73(9):1816-1820.. doi: 10.1080/01635581.2020.1803934. Epub 2020 Aug 13. https://doi.org/10.1080/01635581.2020.1803934

Leinoe E, Kjaersgaard M, Zetterberg E, et al. Highly impaired platelet ultrastructure in two families with novel IKZF5 variants. Platelets. 2021 May 19;32(4):492-497. doi: 10.1080/09537104.2020.1764921. Epub 2020 May 18. https://doi.org/10.1080/09537104.2020.1764921

Lundgaard AY, Josipovic M, Rechner LA, et al. The Feasibility of Implementing Deep Inspiration Breath-Hold for Pediatric Radiation Therapy. International journal of radiation oncology, biology, physics. 2020 Apr 1;106(5):977-984. doi: 10.1016/j.ijrobp.2019.12.025. Epub 2020 Jan 28. https://doi.org/10.1016/j.ijrobp.2019.12.025

Mateos MK, Tulstrup M, Quinn MC, et al. Genome-Wide Association Meta-Analysis of Single-Nucleotide Polymorphisms and Symptomatic Venous Thromboembolism during Therapy for Acute Lymphoblastic Leukemia and Lymphoma in Caucasian Children. Cancers. 2020 May 19;12(5):1285. https://doi.org/10.3390/cancers12051285

Mathiesen S, Sørensen K, Nielsen MM, et al. Male Gonadal Function after Allogeneic Hematopoietic Stem Cell Transplantation in Childhood: A Cross-Sectional, Population-Based Study. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2020;26(9):1635-1645. doi: 10.1016/j.bbmt.2020.05.009. Epub 2020 May 21. https://doi.org/10.1016/j.bbmt.2020.05.009

Nielsen M.M., Mathiesen S, Suominen A, et al. Altered body composition in male long-term survivors of paediatric allogeneic haematopoietic stem cell transplantation: impact of conditioning regimen, chronic graft-versus-host disease and hypogonadism. Bone marrow transplantation. 2020. https://doi.org/10.1038/s41409-020-01038-3

Mirian C, Grønhøj C, Rechnitzer C, et al. Improved Survival of Children, Adolescents, and Young Adults With Head and Neck Soft Tissue Sarcomas in Denmark. Journal of pediatric hematology/oncology. 2020;42(3):175-180. https://doi.org/10.1097/mph.0000000000001615

Mogensen PR, Grell K, Schmiegelow K, et al. Dyslipidemia at diagnosis of childhood acute lymphoblastic leukemia. PloS one. 2020;15(4):e0231209. https://doi.org/10.1371/journal.pone.0231209

Mønster MB, Vissing NH, Schrøder H, et al. Meropenem to Children With Febrile Neutropenia Induces Monoresistant Pseudomonas aeruginosa. Journal of pediatric hematology/oncology. 2020. https://doi.org/10.1097/mph.0000000000001713

Nielsen I, Groth-Pedersen L, Dicroce-Giacobini J, et al. Cationic amphiphilic drugs induce elevation in lysoglycerophospholipid levels and cell death in leukemia cells. Metabolomics: Official journal of the Metabolomic Society. 2020;16(9):91. https://doi.org/10.1007/s11306-020-01710-1

Nielsen MKF, Christensen JF, Frandsen TL, et al. Effects of a physical activity program from diagnosis on cardiorespiratory fitness in children with cancer: a national non-randomized controlled trial. BMC medicine. 2020;18(1):175. https://doi.org/10.1186/s12916-020-01634-6

Nielsen MKF, Christensen JF, Frandsen TL, Thorsteinsson T, Andersen LB, Christensen KB, Wehner PS, Hasle H, Adamsen LØ, Schmiegelow K, Larsen HB. Effects of a physical activity program from diagnosis on cardiorespiratory fitness in children with cancer: a national non-randomized controlled trial. BMC Medicine 2020; 18: 175. https://doi.org/10.1186/s12916-020-01634-6

Norsker FN, Boschini C, Rechnitzer C, Holmqvist AS, Tryggvadottir L, Madanat-Harjuoja LM, Schrøder H, Scheike TH, Hasle H, Winther JF, Andersen KK. Risk of late health effects after soft-tissue sarcomas in childhood – a population-based cohort study within the Adult Life after Childhood Cancer in Scandinavia research program. Acta Oncologica  2020; 59: 1246-1256. https://doi.org/10.1080/0284186X.2020.1794031

Norsker FN, Rechnitzer C, Andersen EW, Linnet KM, Kenborg L, Holmqvist AS, Tryggvadottir L, Madanat-Harjuoja LM, Øra I, Thorarinsdottir HK, Vettenranta K, Bautz A, Schrøder H, Hasle H, Winther JF. Neurologic disorders in long-term survivors of neuroblastoma – a population-based cohort study within the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) research program. Acta Oncologica 2020; 59: 134-40. https://doi.org/10.1080/0284186x.2019.1672892

Pearson ADJ, Zwaan CM, Kolb EA, Karres D, Guillot J, Kim SY, Marshall L, Tasian SK, Smith M, Cooper T, Adamson PC, Barry E, Benettaib B, Binlich F, Borgman A, Brivio E, Capdeville R, Delgado D, Faller DV, Fogelstrand L, Fraenkel PG, Hasle H, Heenen D, Kaspers G, Kieran M, Klusmann JH, Lesa G, Ligas F, Mappa S, Mohamed H, Moore A, Morris J, Nottage K, Reinhardt D, Scobie N, Simko S, Winkler T, Norga K, Reaman G, Vassal G. Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. European Journal of Cancer. 2020; 136: 116-129. https://doi.org/10.1016/j.ejca.2020.04.038

LH Pedersen, A Wahlberg, M Cordt, K Schmiegelow, Dalton SO, Larsen HB. Parent’s perspectives of the pathway to diagnosis of childhood cancer: a matter of diagnostic triage. BMC health services research 2020;20(1),969. https://DOI:10.1186/s12913-020-05821-2

Pierro J, Saliba J, Narang S, et al. The NSD2 p.E1099K Mutation Is Enriched at Relapse and Confers Drug Resistance in a Cell Context-Dependent Manner in Pediatric Acute Lymphoblastic Leukemia. Molecular cancer research: MCR. 2020;18(8):1153-1165. https://doi.org/10.1158/1541-7786.mcr-20-0092

Rank CU, Wolthers BO, Grell K, et al. Asparaginase-Associated Pancreatitis in Acute Lymphoblastic Leukemia: Results From the NOPHO ALL2008 Treatment of Patients 1-45 Years of Age. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020;38(2):145-154. https://doi.org/10.1200/jco.19.02208

Rathe M, Preiss B, Marquart HV, et al. Minimal residual disease monitoring cannot fully replace bone marrow morphology in assessing disease status in pediatric acute lymphoblastic leukemia. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 2020;128(5):414-419. https://doi.org/10.1111/apm.13037

Rathe M, De Pietri S, Wehner PS, et al. Bovine Colostrum Against Chemotherapy-Induced Gastrointestinal Toxicity in Children With Acute Lymphoblastic Leukemia: A Randomized, Double-Blind, Placebo-Controlled Trial. JPEN Journal of parenteral and enteral nutrition. 2020;44(2):337-347. https://doi.org/10.1002/jpen.1528

Regine K, Wittig T, Georgi TW, et al. Comparison of interim PET response to second-line vs. to first-line treatment in classical Hodgkin lymphoma – contribution to the development of response criteria for relapsed or progressive disease. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2021 Mar;62(3):338-341. doi: 10.2967/jnumed.120.247924. Epub 2020 Aug 6. https://doi:10.2967/jnumed.120.247924

Saliba J, Evensen NA, Meyer JA, et al. Feasibility of monitoring peripheral blood to detect emerging clones in children with acute lymphoblastic leukemia(†). Pediatric blood & cancer. 2020;67(7):e28306. https://doi.org/10.1002/pbc.28306

Schmidt-Andersen P, Møller T, Mogensen PR, et al. Feasibility and Validity of the Actiheart Activity Monitor in Children Who Were Hospitalized With Cancer Coadmitted With Classmates: A RESPECT Study. Pediatric physical therapy : the official publication of the Section on Pediatrics of the American Physical Therapy Association. 2020;32(3):226-233. https://doi.org/10.1097/pep.0000000000000712

Schmiegelow K, Rank CU. Management of Asparaginase Toxicity in AYAs with ALL. Clinical lymphoma, myeloma & leukemia. 2020;20 Suppl 1:S12-S13. https://doi.org/10.1016/s2152-2650(20)30444-4

Schmiegelow K. Maintenance therapy of childhood acute lymphoblastic leukemia: Do all roads lead to Rome? Pediatric blood & cancer. 2020:e28418. https://doi.org/10.1002/pbc.28418

Shah Scharff BFS, Modvig S, Thastrup M, et al. A comprehensive clinical study of integrins in acute lymphoblastic leukemia indicates a role of α6/CD49f in persistent minimal residual disease and α5 in the colonization of cerebrospinal fluid. Leukemia & lymphoma. 2020;61(7):1714-1718. https://doi.org/10.1080/10428194.2020.1731500

Thastrup M, Marquart HV, Levinsen M, et al. Correction: Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology study. Leukemia. 2020. https://doi.org/10.1038/s41375-020-0821-1

Thastrup M, Marquart HV, Levinsen M, et al. Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology study. Leukemia. 2020;34(2):336-346. https://doi.org/10.1038/s41375-019-0570-1

Thiele-Nygaard AE, Foss-Skiftesvik J, Juhler M. Intracranial pressure, brain morphology and cognitive outcome in children with sagittal craniosynostosis. Child’s nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery. 2020;36(4):689-695. https://doi.org/10.1007/s00381-020-04502-z

Topperzer MK, Thellesen L, Hoffmann M, et al. Establishment of consensus on content and learning objectives for an interprofessional education in childhood cancer: a Delphi survey. BMJ paediatrics open. 2020;4(1):e000634. https://doi.org/10.1136/bmjpo-2019-000634

Topperzer MK, Larsen HB, Hoffmann M, et al. Response to: Patient-centred medical education: A proposed definition. Medical teacher. 2020;42(3):360-361. https://doi.org/10.1080/0142159x.2019.1625315

Tuckuviene R, Bjerg CL, Jonsson OG, et al. Pulmonary embolism in acute lymphoblastic leukemia – An observational study of 1685 patients treated according to the NOPHO ALL2008 protocol. Research and practice in thrombosis and haemostasis. 2020;4(5):866-871. https://doi.org/10.1002/rth2.12356

Tulstrup M, Moriyama T, Jiang C, et al. Effects of germline DHFR and FPGS variants on methotrexate metabolism and relapse of leukemia. Blood. 2020;136(10):1161-1168. https://doi.org/10.1182/blood.2020005064

Tummala H, Walne AJ, Bewicke-Copley F, Ellison A, Pontikos N, Bridger MG, Rio-Machin A, Sidhu JK, Wang J, Hasle H, Fitzgibbon J, Vulliamy T, Dokal I. A frameshift variant in specificity protein 1 triggers superactivation of Sp1-mediated transcription in familial bone marrow failure. Proceedings of the National Academy of Sciences USA 2020; 117: 17151-5. https://doi.org/10.1073/pnas.2002857117

Uden T, Bertaina A, Abrahamsson J, Ansari M, Balduzzi A, Bourquin JP, Gerhardt C, Bierings M,  Hasle H, Lankester A, Mischke K, Moore AS, Nivison-Smith I, Pieczonka A, Peters C, Sedlacek P, Dirk Reinhardt, Stein J, Versluys B, Wachowiak J, Willems L, Zimmermann M, Locatelli F, Sauer MG. Outcome of Children Relapsing after First Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia: A Retrospective I-BFM Analysis of 333 Children. British Journal of Haematology 2020; 189: 745-50. https://DOI:10.1111/bjh.16441

Volk J, Heck JE, Schmiegelow K, et al. Parental occupational organic dust exposure and selected childhood cancers in Denmark 1968-2016. Cancer epidemiology. 2020;65:101667. https://doi.org/10.1016/j.canep.2020.101667

Vonasek J, Edslev PW, d’Amore F, Hasle H. Brentuximab vedotin monotherapy is an effective treatment in a frail pediatric patient with Down syndrome and classical Hodgkin lymphoma. Pediatric Blood & Cancer 2020; 67: e28082. https://doi.org/10.1002/pbc.28082

Weibel M, Nielsen MKF, Topperzer MK, et al. Back to school with telepresence robot technology: A qualitative pilot study about how telepresence robots help school-aged children and adolescents with cancer to remain socially and academically connected with their school classes during treatment. Nursing open. 2020;7(4):988-997. https://doi.org/10.1002/nop2.471

Wibroe M, Ingersgaard MV, Larsen HB, et al. Living with the cerebellar mutism syndrome: long-term challenges of the diagnosis. Acta neurochirurgica. 2020. https://doi.org/10.1007/s00701-020-04479-3

Wolfs TFW, Attarbaschi A, Balduzzi A, Bernardo ME, Bomken S, Borkhardt A, Bourquin JP, Dufour C, Gennery A, Grainger J, Hasle H, Hrusak O, Izraeli S, Mechinaud F, Trka J, Vormoor J. COVID-19 – Impact on Childhood Haematology Patients. HemaSphere 2020; 11 :e465. https://doi.org/10.1097/hs9.0000000000000465

Yang X, Song H, Leslie G, et al. Ovarian and breast cancer risks associated with pathogenic variants in RAD51C and RAD51D. Journal of the National Cancer Institute. 2020 Dec 14;112(12):1242-1250. doi: 10.1093/jnci/djaa030. https://doi.org/10.1093/jnci/djaa030

Yang X, Leslie G, Doroszuk A, et al. Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020;38(7):674-685. https://doi.org/10.1200/jco.19.01907

Østergaard A, Bohnstedt C, Grell K, et al. Acute lymphoblastic leukemia and down syndrome: 6-mercaptopurine and methotrexate metabolites during maintenance therapy. Leukemia. 2021 Mar;35(3):863-866. doi: 10.1038/s41375-020-0946-2. Epub 2020 Jul 4. https://doi.org/10.1038/s41375-020-0946-2